1,283,719 Shares in Doximity, Inc. (NASDAQ:DOCS) Bought by Norges Bank

Norges Bank purchased a new stake in Doximity, Inc. (NASDAQ:DOCSFree Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 1,283,719 shares of the company’s stock, valued at approximately $35,995,000. Norges Bank owned 0.69% of Doximity at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in the business. Vanguard Group Inc. increased its stake in Doximity by 5.9% in the third quarter. Vanguard Group Inc. now owns 11,038,475 shares of the company’s stock valued at $234,236,000 after acquiring an additional 616,157 shares during the period. Baillie Gifford & Co. raised its holdings in shares of Doximity by 0.9% in the 3rd quarter. Baillie Gifford & Co. now owns 6,656,242 shares of the company’s stock worth $141,245,000 after buying an additional 57,078 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its position in shares of Doximity by 10.7% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 699,066 shares of the company’s stock worth $14,834,000 after buying an additional 67,363 shares during the period. AQR Capital Management LLC boosted its stake in Doximity by 344.2% in the 3rd quarter. AQR Capital Management LLC now owns 540,126 shares of the company’s stock valued at $11,461,000 after buying an additional 418,523 shares in the last quarter. Finally, Natixis Advisors L.P. grew its position in Doximity by 48.5% in the fourth quarter. Natixis Advisors L.P. now owns 522,115 shares of the company’s stock valued at $14,640,000 after acquiring an additional 170,536 shares during the period. Institutional investors and hedge funds own 87.19% of the company’s stock.

Insider Activity

In related news, insider Craig Overpeck sold 1,500 shares of the business’s stock in a transaction that occurred on Thursday, May 16th. The shares were sold at an average price of $23.85, for a total transaction of $35,775.00. Following the completion of the sale, the insider now directly owns 108,609 shares of the company’s stock, valued at $2,590,324.65. The transaction was disclosed in a legal filing with the SEC, which is available at this link. In other Doximity news, Director Kira Scherer Wampler sold 2,500 shares of the stock in a transaction dated Friday, May 17th. The stock was sold at an average price of $27.22, for a total value of $68,050.00. Following the transaction, the director now owns 10,258 shares of the company’s stock, valued at $279,222.76. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, insider Craig Overpeck sold 1,500 shares of the business’s stock in a transaction dated Thursday, May 16th. The stock was sold at an average price of $23.85, for a total value of $35,775.00. Following the transaction, the insider now owns 108,609 shares of the company’s stock, valued at $2,590,324.65. The disclosure for this sale can be found here. In the last quarter, insiders have sold 6,500 shares of company stock valued at $171,250. 39.40% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several equities research analysts have recently commented on DOCS shares. Evercore ISI boosted their target price on shares of Doximity from $28.00 to $29.00 and gave the company an “in-line” rating in a research note on Friday, May 17th. Needham & Company LLC reaffirmed a “hold” rating on shares of Doximity in a report on Friday, May 17th. Leerink Partnrs reissued a “market perform” rating on shares of Doximity in a report on Monday, February 26th. Wells Fargo & Company raised their price target on Doximity from $25.00 to $27.00 and gave the company an “equal weight” rating in a report on Friday, February 9th. Finally, William Blair reissued an “outperform” rating on shares of Doximity in a research note on Friday, May 17th. One equities research analyst has rated the stock with a sell rating, eleven have issued a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $28.73.

Read Our Latest Research Report on Doximity

Doximity Stock Down 2.6 %

Shares of DOCS stock opened at $27.78 on Friday. The firm has a market cap of $5.18 billion, a price-to-earnings ratio of 38.58, a PEG ratio of 5.16 and a beta of 1.18. Doximity, Inc. has a 12 month low of $19.71 and a 12 month high of $36.29. The stock has a 50-day moving average price of $25.68 and a 200 day moving average price of $26.85.

Doximity Profile

(Free Report)

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

Further Reading

Want to see what other hedge funds are holding DOCS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Doximity, Inc. (NASDAQ:DOCSFree Report).

Institutional Ownership by Quarter for Doximity (NASDAQ:DOCS)

Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.